Prescription coverage in indigent patients affects the use of long-acting opioids in the management of cancer pain

Pain Medicine (United States)

Volumn 15, Issue 1, 2014, Pages 42-51

  Wieder, Robert ^a   Delarosa, Nila ^b   Bryan, Margarette ^a   Hill, Ann Marie ^c   Amadio, William J ^d  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d RIDER UNIVERSITY   (United States)

Author keywords

Analgesic; Cancer pain; Disparities; Ethnic; Indigent; Narcotics; Pain management; Racial

Indexed keywords

FENTANYL; MORPHINE SULFATE; OXYCODONE;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; ASIAN; BREAST CARCINOMA; BREAST SARCOMA; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER STAGING; COLORECTAL TUMOR; COMPARATIVE STUDY; DRUG USE; EMERGENCY WARD; ETHNICITY; FAILURE TO THRIVE; FEMALE; FOLLOW UP; GENDER; GERM CELL TUMOR; HEAD AND NECK TUMOR; HISPANIC; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INDIGENT; LUNG TUMOR; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL RECORD REVIEW; MIDDLE AGED; MINORITY GROUP; MULTIPLE MYELOMA; OUTPATIENT; PAIN ASSESSMENT; PANCREAS CARCINOMA; PATIENT COMPLIANCE; PRESCRIPTION; PRESCRIPTION COVERAGE; SINGLE DRUG DOSE; SMOKING; SOCIAL WELFARE; SUBSTANCE ABUSE; SUBSTANCE USE; UTERINE CERVIX CARCINOMA;

ANALGESIC; CANCER PAIN; DISPARITIES; ETHNIC; INDIGENT; NARCOTICS; PAIN MANAGEMENT; RACIAL;

ADULT; ALCOHOLISM; CHRONIC PAIN; DELAYED-ACTION PREPARATIONS; DRUG UTILIZATION; ETHNIC GROUPS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MEDICAID; MEDICAL INDIGENCY; MEDICATION ADHERENCE; MIDDLE AGED; MINORITY GROUPS; NARCOTICS; NEOPLASMS; NEW JERSEY; PAIN MANAGEMENT; PAIN MEASUREMENT; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SMOKING; SUBSTANCE-RELATED DISORDERS; UNITED STATES; URBAN POPULATION;

EID: 84892515817     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12238     Document Type: Article

References (31)

1. Cleeland CS, Gonin R, Hatfield AK, etal. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-596.
2. Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ. Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med 1997;127:813-816.
3. Teunissen SC, Wesker W, Kruitwagen C, etal. Symptom prevalence in patients with incurable cancer: A systematic review. J Pain Symptom Manage 2007;34:94-104.
4. Dy SM. Evidence-based approaches to pain in advanced cancer. Cancer J 2010;16:500-506.
5. Dy SM, Asch SM, Naeim A, etal. Evidence-based standards for cancer pain management. J Clin Oncol 2008;26:3879-3885.
6. Chang VT, Hwang SS, Kasimis B. Longitudinal documentation of cancer pain management outcomes: A pilot study at a VA medical center. J Pain Symptom Manage 2002;24:494-505.
7. Dionne RA, Bartoshuk L, Mogil J, Witter J. Individual responder analyses for pain: Does one pain scale fit all? Trends Pharmacol Sci 2005;26:125-130.
8. Farrar JT, Polomano RC, Berlin JA, Strom BL. A comparison of change in the 0-10 numeric rating scale to a pain relief scale and global medication performance scale in a short-term clinical trial of breakthrough pain intensity. Anesthesiology 2010;112:1464-1472.
9. National Comprehensive Cancer Network. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for Adult Cancer Pain V.I.; 2007. Available at: http://www.nccn.org/professionals/physician_gls/PDF/pain.pdf (accessed January 2, 2012).
10. Rhodes DJ, Koshy RC, Waterfield WC, Wu AW, Grossman SA. Feasibility of quantitative pain assessment in outpatient oncology practice. J Clin Oncol 2001;19:501-508.
11. Carr DB, Goudas LC, Balk EM, etal. Evidence report on the treatment of pain in cancer patients. J Natl Cancer Inst Monogr 2004;32:23-31.
12. Du Pen SL, Du Pen AR, Polissar N, etal. Implementing guidelines for cancer pain management: Results of a randomized controlled clinical trial. J Clin Oncol 1999;17:361-370.
13. Cleeland CS, Portenoy RK, Rue M, etal. Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. Ann Oncol 2005;16:972-980.
14. Klepstad P, Kaasa S, Jystad A, Hval B, Borchgrevink PC. Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: A randomized, double-blind trial. Pain 2003;101:193-198.
15. Gatti A, Reale C, Occhioni R, etal. Standard therapy with opioids in chronic pain management: ORTIBER (ORamorph in TIBER) study. Clin Drug Investig 2009;29(suppl 1):17-23.
16. Tassinari D, Sartori S, Tamburini E, etal. Transdermal fentanyl as a front-line approach to moderate-severe pain: A meta-analysis of randomized clinical trials. J Palliat Care 2009;25:172-180.
17. Rauck RL. What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review. Pain Pract 2009;9:468-479.
18. Bernabei R, Gambassi G, Lapane K, etal. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 1998;279:1877-1882.
19. Edwards RR, Fillingim RB, Ness TJ. Age-related differences in endogenous pain modulation: A comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain 2003;101:155-165.
20. Johnson VM, Teno JM, Bourbonniere M, Mor V. Palliative care needs of cancer patients in U.S. nursing homes. J Palliat Med 2005;8:273-279.
21. Bartfield JM, Salluzzo RF, Raccio-Robak N, Funk DL, Verdile VP. Physician and patient factors influencing the treatment of low back pain. Pain 1997;73:209-211.
22. Todd KH, Lee T, Hoffman JR. The effect of ethnicity on physician estimates of pain severity in patients with isolated extremity trauma. JAMA 1994;271:925-928.
23. Cleeland CS, Mendoza TR, Wang XS, etal. Levels of symptom burden during chemotherapy for advanced lung cancer: Differences between public hospitals and a tertiary cancer center. J Clin Oncol 2011;29:2859-2865.
24. Green CR, Anderson KO, Baker TA, etal. The unequal burden of pain: Confronting racial and ethnic disparities in pain. Pain Med 2003;4:277-294.
25. Bryan M, De La Rosa N, Hill AM, etal. Influence of prescription benefits on pain control in patients with cancer. Pain Med 2008;9:1148-1157.
26. Demidenko E. Sample size determination for logistic regression revisited. Stat Med 2007;26:3385-3397.
27. Hosmer D, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 2000:339-347.
28. Fujimura T, Takahashi S, Kume H, etal. Cancer-related pain and quality of life in prostate cancer patients: Assessment using the Functional Assessment of Prostate Cancer Therapy. Int J Urol 2009;16:522-525.
29. Reyes-Gibby CC, Shete S, Yennurajalingam S, etal. Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: Assessing the influence of cytokine genes. J Pain Symptom Manage 2009;38:894-902.
30. Anderson KO, Mendoza TR, Valero V, etal. Minority cancer patients and their providers: Pain management attitudes and practice. Cancer 2000;88:1929-1938.
31. Mayer DK, Travers D, Wyss A, Leak A, Waller A. Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina. J Clin Oncol 2011;29:2683-2688.